Blog

Categories

Companion Diagnostics (CDx)—A Central Laboratory Perspective Companion Diagnostics Alan Wookey Companion Diagnostics (CDx)—A Central Laboratory Perspective
In the June issue of Inside Precision Medicine, Alan Wookey, Vice President Companion Diagnostics and Q2 Solutions’ scientific advisor, explores the evolution of companion diagnostics (CDx) since the...
 Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab Central Laboratories Patrice Hugo, Ph.D. Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab
In the June issue of Contract Pharma, Q2 Solution's Chief Scientific Officer Patrice Hugo discusses the breadth of new tech-enabled analytical laboratory techniques that are making an impact in...
 Quality FFPE analysis at single cell resolution: elevating single cell RNA sequencing innovation to the next level for optimized drug discovery and development Genomics Q² Solutions Quality FFPE analysis at single cell resolution: elevating single cell RNA sequencing innovation to the next level for optimized drug discovery and development
Authors: Joseph Modarelli, Adam Black and Douglas Wilson
 Three key decisions cell and gene therapy trial sponsors need to make early into drug development Alan Wookey Three key decisions cell and gene therapy trial sponsors need to make early into drug development
In the rapidly growing and innovative therapeutic area, how do clinical trial sponsors effectively navigate the multitude of unique intricacies involved in cell and gene therapy development? In a...
 Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials Genomics David Latto, PhD Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials
As pharmaceutical and biotech companies understand the value of cellular-level insights to further personalize patient care, advancements in genomic laboratory capabilities are growing in interest. ...
 Cell therapy: devising a full clinical development plan Central Laboratories Alan Wookey Cell therapy: devising a full clinical development plan
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.Showcasing our IQVIA Connected...
 Improving Pediatric R&D Success: Integrating the Younger Patient and Caregiver’s Perspective into Trial Design Central Laboratories Charlie Fix Improving Pediatric R&D Success: Integrating the Younger Patient and Caregiver’s Perspective into Trial Design
Given the multitude of nuances to consider when conducting a pediatric trail, it is vital that sponsor form a comprehensive strategy early in the trail design. Q2 Solutions' Charlie Fix along with...
 Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma Genomics Q² Solutions Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Cell Reports article, with contributions from Martin Buchkovich, Q2 Solutions Genomics Highlights
 Building a Greener Lab Q² Solutions Building a Greener Lab
Why a roadmap towards more sustainable science is essential to improve the environmental impact of pathology labs everywhere
 Benefits of Digital Pathology for Clinical Trial Sponsors and Pathology Teams Digital Pathology Monika Lamba, MD, Ph.D. Benefits of Digital Pathology for Clinical Trial Sponsors and Pathology Teams
Can advances in tech-enabled solutions and workflows optimize diagnostic analysis while reducing the burden on pathologists?